Literature DB >> 15972238

Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice.

Michelle M Sidor1, Boris Sakic, Paul M Malinowski, David A Ballok, Curtis J Oleschuk, Joseph Macri.   

Abstract

The systemic autoimmune disease lupus erythematosus (SLE) is frequently accompanied by neuropsychiatric manifestations and brain lesions of unknown etiology. The MRL-lpr mice show behavioral dysfunction concurrent with progression of a lupus-like disease, thus providing a valuable model in understanding the pathogenesis of autoimmunity-induced CNS damage. Profound neurodegeneration in the limbic system of MRL-lpr mice is associated with cytotoxicity of their cerebrospinal fluid (CSF) to mature and immature neurons. We have recently shown that IgG-rich CSF fraction largely accounts for this effect. The present study examines IgG levels in serum and CSF, as well as the permeability of the blood-brain barrier in mice that differ in immune status, age, and brain morphology. In comparison to young MRL-lpr mice and age-matched congenic controls, a significant elevation of IgG and albumin levels were detected in the CSF of aged autoimmune MRL-lpr mice. Two-dimensional gel electrophoresis and MALDI-TOF MS confirmed elevation in IgG heavy and Ig light chain isoforms in the CSF. Increased permeability of the blood-brain barrier correlated with neurodegeneration (as revealed by Fluoro Jade B staining) in periventricular areas. Although the source and specificity of neuropathogenic antibodies remain to be determined, these results support the hypothesis that a breached blood-brain barrier and IgG molecules are involved in the etiology of CNS damage during SLE-like disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972238      PMCID: PMC1635784          DOI: 10.1016/j.jneuroim.2005.04.022

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  72 in total

1.  A method to produce Ponceau replicas from blots: application for Western analysis.

Authors:  J Gotzmann; C Gerner
Journal:  Electrophoresis       Date:  2000-02       Impact factor: 3.535

2.  Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration.

Authors:  L C Schmued; K J Hopkins
Journal:  Brain Res       Date:  2000-08-25       Impact factor: 3.252

3.  Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice.

Authors:  D Maric; J M Millward; D A Ballok; H Szechtman; J A Denburg; J L Barker; B Sakic
Journal:  Brain Res       Date:  2001-11-30       Impact factor: 3.252

4.  Cardiac sarcoplasmic reticulum and sarcolemmal proteins separated by two-dimensional electrophoresis: surfactant effects on membrane solubilization.

Authors:  J Macri; B McGee; J N Thomas; P Du; T I Stevenson; G W Kilby; S T Rapundalo
Journal:  Electrophoresis       Date:  2000-05       Impact factor: 3.535

5.  A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus.

Authors:  L A DeGiorgio; K N Konstantinov; S C Lee; J A Hardin; B T Volpe; B Diamond
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

6.  Immunoglobulin binding to brain in autoimmune mice.

Authors:  A Zameer; S A Hoffman
Journal:  J Neuroimmunol       Date:  2001-11-01       Impact factor: 3.478

Review 7.  The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation.

Authors:  F G I Jennekens; L Kater
Journal:  Rheumatology (Oxford)       Date:  2002-06       Impact factor: 7.580

8.  Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity.

Authors:  S Hirohata; S Hirose; T Miyamoto
Journal:  Arch Intern Med       Date:  1985-10

Review 9.  Imaging modalities in central nervous system systemic lupus erythematosus.

Authors:  T W Huizinga; S C Steens; M A van Buchem
Journal:  Curr Opin Rheumatol       Date:  2001-09       Impact factor: 5.006

10.  Congenic autoimmune murine models of central nervous system disease in connective tissue disorders.

Authors:  E L Alexander; E D Murphy; J B Roths; G E Alexander
Journal:  Ann Neurol       Date:  1983-08       Impact factor: 10.422

View more
  18 in total

Review 1.  Neuroimmunopathology in a murine model of neuropsychiatric lupus.

Authors:  David A Ballok
Journal:  Brain Res Rev       Date:  2006-12-20

2.  Total protein is an effective loading control for cerebrospinal fluid western blots.

Authors:  Mahlon A Collins; Jiyan An; Danielle Peller; Robert Bowser
Journal:  J Neurosci Methods       Date:  2015-05-22       Impact factor: 2.390

Review 3.  Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus.

Authors:  Meggan Mackay
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

4.  Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice.

Authors:  Kelly K Anderson; David A Ballok; Neena Prasad; Henry Szechtman; Boris Sakic
Journal:  Behav Brain Res       Date:  2005-09-23       Impact factor: 3.332

5.  Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.

Authors:  Boris Sakic; David L Kirkham; David A Ballok; James Mwanjewe; Ian M Fearon; Joseph Macri; Guanhua Yu; Michelle M Sidor; Judah A Denburg; Henry Szechtman; Jonathan Lau; Alexander K Ball; Laurie C Doering
Journal:  J Neuroimmunol       Date:  2005-09-29       Impact factor: 3.478

6.  Anti-alpha-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis.

Authors:  Xiao-ye Lu; Xiao-xiang Chen; Li-dong Huang; Chang-qing Zhu; Yue-ying Gu; Shuang Ye
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

7.  Purine receptor antagonist modulates serology and affective behaviors in lupus-prone mice: evidence of autoimmune-induced pain?

Authors:  David A Ballok; Boris Sakic
Journal:  Brain Behav Immun       Date:  2008-06-14       Impact factor: 7.217

8.  Effects of prolonged treatment with memantine in the MRL model of CNS lupus.

Authors:  Katarina Marcinko; Tiffany Parsons; Jason P Lerch; John G Sled; Boris Sakic
Journal:  Clin Exp Neuroimmunol       Date:  2012-09

9.  Depression is an early disease manifestation in lupus-prone MRL/lpr mice.

Authors:  Hua-Xin Gao; Sean R Campbell; Min-Hui Cui; Pu Zong; Jong Hee-Hwang; Maria Gulinello; Chaim Putterman
Journal:  J Neuroimmunol       Date:  2009-01-03       Impact factor: 3.478

Review 10.  Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.

Authors:  Hélène Jeltsch-David; Sylviane Muller
Journal:  Nat Rev Neurol       Date:  2014-09-09       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.